A common definition is antibodies produced in their germ-line configuration in the absence of exogenous antigenic trigger. interactions with the microbiota. == Introduction == While scientific progress is rarely straightforward, IgAs Odyssey seems particular confusing. IgA is the most abundantly produced antibody isotype but was the last isotype to be discovered. Research on IgA biology has dominated the emerging field of mucosal immunology and today we experience an exciting increase in the number of high impact studies on IgA. Nonetheless, we are lacking a comprehensive picture. Extensive work has been performed to study pathways of IgA generation and IgA memory but experts in the field barely agree on the relevance of IgA inductive sites and mechanisms.1,2Counting ourselves as IgA supporters, we suggest that much of the confusion in the discipline might come from linguistic and biological oversimplifications. Aiming to avoid such inaccuracies, in this review, we will singly discuss new aspects in intestinal secretory IgA (SIgA) biology. We will base our Naftopidil 2HCl conversation on critical definitions in IgA biology (observe also Box1) and focus on the conversation between SIgA and the intestinal microbiota. For an overview of IgA inductive compartment and class switch recombination please refer to Box2Fast details on SIgA and recommendations therein. We emphasize that concepts in intestinal SIgA biology discussed here should not be applied lightheartedly to other mucosal tissues such as lung, eye, and urogenital tract or monomeric IgA predominantly present in serum. IgA shares the archetypical structure of other human and rodent antibody isotypes and is composed of Fab fragments and an Fc region each consisting of several Ig domains (Fig.1a). However, unlike IgG and IgA in serum, in the human and murine gut, IgA is produced as polymeric IgA (pIgA), foremost as dimeric IgA. The dimeric form of IgA consists of an antibody dimer with two Ig monomers linked tail-to-tail through extensions of the terminal Ig domain name of their Fc portion and a protein called joining (J) Naftopidil 2HCl chain.3Expression of polymeric IgA linked by a J chain is a distinguishing feature of mucosal plasma cells and distinguishes them from plasma cells in many other compartments such as spleen and bone marrow. Thus, the structure of intestinal pIgA is usually fundamentally different from the prevailing monomeric form of IgA present in human plasma. == Fig. 1. == Secretory IgA is usually formed by the combined function of plasma cells Naftopidil 2HCl generating multimeric IgA and epithelial cells expressing pIgRaSchematic diagrams illustrating the structure of human dimeric IgA1, human dimeric IgA2, human secretory IgA1, and the free secretory component (SC, which is a cleavage product of pIgR). Both, human IgA1 and IgA2 show the canonical antibody structure of two heavy and two light chains building Fab and Fc portions of the antibody. Human IgA1 is characterized by an extended hinge region linking the Fab and Fc part. In dimeric IgA, two antibody monomers are covalently bound through disulfide bonds to the J chain. Secretory component covalently bound to IgA differs in its conformation from free SC. Consequently, free SC and bound SC might have different microbiota binding capacity.bTranscytosis of pIgR/dIgA complexes results from initial acknowledgement binding, conformational changes, and final binding before the complex becomes transcytosed. Following transcytosis, free SC, and SIgA are released into the gut lumen (here depicted for human IgA1). Illustrations adapted from refs.4,68 The polymeric structure of IgA is a prerequisite for its active transport across mucosal surfaces and secretion. This process is usually carried out by the polymeric Ig receptor (pIgR). However pIgR does not only transport multimeric IgA but contributes the secretory component that is covalently bound to the antibody portion and constitutes an integral part of the SIgA complex (Fig.1). Thus, effectively SIgA is usually a chimeric molecule generated by the combined activity of both Cav2.3 plasma cells and pIgR-expressing (mostly epithelial) cells. Consistently, production.